Back to Search
PETER KALDIS, M.D.
M.D.
Hospitalist Physician
NPI: 1144578782IndividualAccepts Medicare
Specialties, Licenses & Credentials
Education
UNIVERSITY OF TEXAS MEDICAL SCHOOL AT HOUSTON
Class of 2012
Research & Publications (20)
Cdk2 and Cdk4 activities are dispensable for tumorigenesis caused by the loss of p53.
PMID 19307310·Mol Cell Biol·2009
7-preclinical
Genetic mouse models to investigate cell cycle regulation.
PMID 19418238·Transgenic Res·2009
7-preclinical
Rb/Cdk2/Cdk4 triple mutant mice elicit an alternative mechanism for regulation of the G1/S transition.
PMID 19129496·Proc Natl Acad Sci U S A·2009
7-preclinical
Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms.
PMID 19561645·Oncogene·2009
6-review
Cdk2 plays a critical role in hepatocyte cell cycle progression and survival in the setting of cyclin D1 expression in vivo.
PMID 19652536·Cell Cycle·2009
7-preclinical
p21 Inhibits Cdk1 in the absence of Cdk2 to maintain the G1/S phase DNA damage checkpoint.
PMID 17942597·Mol Biol Cell·2008
7-preclinical
Genetic substitution of Cdk1 by Cdk2 leads to embryonic lethality and loss of meiotic function of Cdk2.
PMID 18787066·Development·2008
7-preclinical
Cyclin-dependent kinase 2 signaling regulates myocardial ischemia/reperfusion injury.
PMID 18692063·J Mol Cell Cardiol·2008
7-preclinical
The metastasis-associated gene Prl-3 is a p53 target involved in cell-cycle regulation.
PMID 18471976·Mol Cell·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 6560 FANNIN ST STE 1632
HOUSTON, TX 77030 - Phone
- (713) 500-6525
Quick Facts
- NPI
- 1144578782
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 14
- Publications
- 20
Are you this provider?
Claim Your Profile